Currently Browsing: The Montreal Gazette

Largest Canadian study on dementia hopes to develop new treatments and interventions

Karen Seidman, Montreal Gazette

The largest Canadian study ever on dementia launches Wednesday with a goal of developing new interventions to slow or halt diseases that affect more than half a million Canadians.The clinical study on neurodegenerative diseases is being conducted by the Canadian Consortium on Neurodegeneration in Aging. It will be administered by the consortium’s scientific director Dr. Howard Chertkow, a neurologist at the Jewish General Hospital. A network of 350 researchers across the country is mobilizing in an attempt to untangle some of the mysteries of age-related brain diseases such as Alzheimer’s and other forms of dementia.The goal is to enrol 1,600 participants at 30 sites in Canada to study dementia in all its forms, in the hope of creating strategies for early detection and intervention and improving the lives of those living with dementia.
An estimated 564,000 Canadians live with dementia, but the number is expected to soar to 937,000 by 2031. Left unchecked, one in five people in the country risk developing Alzheimer’s or other types of dementia. Worldwide, the cost of treating dementia is expected to reach $1 trillion by 2018. “We really have to mobilize and fight this disease, which is such a tragedy and a burden,” Chertkow said in an interview. “This represents the Canadian government realizing it’s time to step up to the plate and create a national dementia strategy.”
Read the rest here:

Health Canada releases new labeling standards for acetaminophen products

Steven Senne, The Canadian Press, Montreal Gazette

OTTAWA — Health Canada has released updated labelling standards for over-the-counter products containing acetaminophen to try to reduce the risk of liver damage.

The department says the changes will include clearer instructions on packages that encourage using the lowest possible dose, not exceeding the recommended daily amount of 4,000 mg for adults and not using products for more than five days for pain or three days for a fever. The announcement follows a Health Canada safety review on acetaminophen in 2015. Label changes are set to apply immediately for companies seeking to introduce new products on the Canadian market.

Read the rest here:

Search for victims continues in L’Isle-Verte

Official death toll reaches 16, with another 16 residents still considered missing

The Montreal Gazette, Catherine Solyom

L’Isle-Verte, Québec – As crews continued to search the ruins of the Résidence du Havre for the remaining 16 people who are still considered missing after the fire, journalists got a first glimpse on Tuesday of the charred and frozen site behind the orange police tape where the seniors’ home for 52 people once stood.